GENOPTIX INC 4

4 · GENOPTIX INC · Filed Nov 5, 2007

Form 4

Period: 2007-11-02

Director

Transactions

Conversion
Common Stock
2007-11-02+356,154→ 369,477 total(indirect: see footnote)
Conversion
Series 1-A Preferred Stock
2007-11-02−1,691,730→ 0 total(indirect: see footnote)
→ Common Stock (356,154 underlying)
Conversion
Series 1-C Preferred Stock
2007-11-02−921,729→ 0 total(indirect: see footnote)
→ Common Stock (194,047 underlying)
Conversion
Common Stock
2007-11-02+372,348→ 741,825 total(indirect: see footnote)
Conversion
Series 1-B Preferred Stock
2007-11-02−1,768,654→ 0 total(indirect: see footnote)
→ Common Stock (372,348 underlying)
Conversion
Common Stock
2007-11-02+194,047→ 935,872 total(indirect: see footnote)
Conversion
Series 1-D Preferred Stock
2007-11-02−1,081,891→ 0 total(indirect: see footnote)
→ Common Stock (227,765 underlying)
Conversion
Common Stock
2007-11-02+227,765→ 1,163,637 total(indirect: see footnote)
Sale
Common Stock
2007-11-02$17.00/sh−107,717$1,831,189→ 1,055,920 total(indirect: see footnote)

Footnotes (9)

[F1]Each 4.75 shares of Series 1-A Preferred Stock converted into one share of the Issuer's common stock for no additional consideration and had no expiration date.
[F2]See Exhibit 99.
[F3]Each 4.75 shares of Series 1-B Preferred Stock converted into one share of the Issuer's common stock for no additional consideration and had no expiration date.
[F4]See Exhibit 99.
[F5]Each 4.75 shares of Series 1-C Preferred Stock converted into one share of the Issuer's common stock for no additional consideration and had no expiration date.
[F6]See Exhibit 99.
[F7]Each 4.75 shares of Series 1-D Preferred Stock converted into one share of the Issuer's common stock for no additional consideration and had no expiration date.
[F8]See Exhibit 99.
[F9]See Exhibit 99.

Documents

2 files